ArticleMedical science monitor : international medical journal of experimental and clinical research2017

Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.

Xicai Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.